
Chemical and Pharmaceutical Bulletin p. 184 - 193 (2000)
Update date:2022-09-26
Topics:
Okada, Yoshio
Matsumoto, Yoshikazu
Tsuda, Yuko
Tada, Mayako
Wanaka, Keiko
Hijikata-Okunomiya, Akiko
Okamoto, Shosuke
Various compounds were synthesized by combining three components at positions P1, P1, and P2,. Of these, N-(trans-4- aminomethylcyclohexanecarbonyl)-Tyr(O-2-bromobenzyloxycarbonyl)-octylamide inhibited plasmin selectively with IC50 values of 0.80 and 0.23 μM towards S-2251 and fibrin, respectively. This compound also inhibited plasma kallikrein, urokinase, thrombin and trypsin with IC50 values of 10, >50, >50 and 1.6 μM, respectively.
View MoreBeijing Top Science biological technology co., LTD
Contact:+86-13439059536
Address:15-1705 jre three mile, Beijing 100000,CHINA
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
Yicheng Goto Pharmaceuticals Co.,Ltd.
Contact:+86 710 3423122
Address:5th Floor,East Gate of Building #2,Servo-Industrial Park,1st Qilin Road,Xiangyang,Hubei,China
Changsha Nutritopper Bio Technology Co.,Ltd.
Contact:+86-731-87803543
Address:East 1st Street, Baima Road, Ningxiang County
Doi:10.1021/ja01349a029
(1932)Doi:10.1080/00397910008087117
(2000)Doi:10.1021/jo00803a026
(1971)Doi:10.1016/j.tetasy.2016.11.007
(2017)Doi:10.1016/j.poly.2012.06.079
(2013)Doi:10.1021/om400130m
(2013)